SEC Form 4 · accession 0001179110-15-006830
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger Bird
Officer — Senior Vice President
Period of report
Apr 27, 2015
Accepted (ET)
Apr 29, 2015 · 6:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Apr 27, 2015 | M | 13,527 | $21.2194 | A | 55,537 | D | |
| Common shares without par value | Apr 27, 2015 | M | 10,821 | $25.2461 | A | 66,358 | D | |
| Common shares without par value | Apr 27, 2015 | S | 100 | $47.575 | D | 66,258 | D | |
| Common shares without par value | Apr 27, 2015 | S | 300 | $47.57 | D | 65,958 | D | |
| Common shares without par value | Apr 27, 2015 | S | 5,953 | $47.571 | D | 60,005 | D | |
| Common shares without par value | Apr 27, 2015 | S | 11,195 | $47.561 | D | 48,810 | D | |
| Common shares without par value | Apr 27, 2015 | S | 500 | $47.562 | D | 48,310 | D | |
| Common shares without par value | Apr 27, 2015 | S | 900 | $47.57 | D | 47,410 | D | |
| Common shares without par value | Apr 27, 2015 | S | 5,400 | $47.56 | D | 42,010 | D | |
| Common shares without par value | Apr 27, 2015 | S | 2,866 | $47.57 | D | 39,144 | D | |
| Common shares without par value | Apr 27, 2015 | S | 1,334 | $47.58 | D | 37,810 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $21.2194 | Apr 27, 2015 | M | 13,527 | D | Feb 17, 2009 | Feb 16, 2016 | Common shares | 13,527 | 0 | D |
| Option (right to buy)F1 | $25.2461 | Apr 27, 2015 | M | 10,821 | D | Feb 16, 2010 | Feb 15, 2017 | Common shares | 10,821 | 0 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.